Chronic heart failure with reduced EF: A decade of major pharmacological innovations - 19/01/24
Abstract |
Background and objectives |
Because of its severity, prevalence, and medical economic importance, heart failure is a chronic disease that is the subject of intense medical research. The aim of this article was to review the therapeutic innovations of the last decade that have been incorporated into the latest international recommendations for the treatment of heart failure.
Method |
Review of literature and current guidelines.
Conclusion |
The results of the clinical trials reviewed here represent major advances that will have a significant impact on quality of life, survival, rehospitalisation and, for certain treatments, a beneficial joint effect on commonly associated comorbidities such as diabetes and chronic renal failure.
Le texte complet de cet article est disponible en PDF.Plan
Vol 53 - N° 1
Article 104219- mars 2024 Retour au numéro
Article précédent
- New insights in acute heart failure
- Ayu Asakage, Alexandre Mebazaa, Benjamin Deniau
- Electrical therapies in heart failure: Evolving technologies and indications
- Cecilia Linde
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?